Showing results (41-50 of 368) with videos related to
Sort By:
Pageof 37
Frontiers in Endocrinology|October 11, 2023
Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world settingSandy Maumus-Robert, Ana Jarne-Munoz, Antoine Pariente, et al.Cardiovascular Drugs and Therapy|August 26, 2021
Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality AnalysisAmandine Gouverneur, Paola Sanchez-Pena, Gwenaelle Veyrac, et al.Scientific Reports|March 3, 2026
PCSK9 inhibitors patterns of use in France from nationwide repeated cross-sectional and cohort studiesAllison Singier, Anne Bénard-Laribière, Ana Jarne-Munoz, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 25, 2025
Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort StudyNathan du Soulier, Antoine Pariente, Julien Bezin, et al.Journal of Women'S Health (2002)|November 18, 2025
Sex Differences in the Use and Discontinuation of Recommended Drugs in Secondary Ischemic Stroke Prevention: A Regional Registry-Based AnalysisJulia Perrier, Sandrine Domecq, Emilie Lesaine, et al.Fundamental & Clinical Pharmacology|March 17, 2025
Second primary cancers and hormonal therapies for prostate cancer: A nested case-control studyLucie-Marie Scailteux, Julien Bezin, Marion Gundelwein, et al.Frontiers in Pharmacology|April 11, 2019
Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence StudyLouis Létinier, Sébastien Cossin, Yohann Mansiaux, et al.Drug Safety|July 1, 2017
Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting DatabaseCécile Pageot, Julien Bezin, Andy Smith, et al.Pharmacological Research|July 21, 2020
Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysisIris Pujade, Justine Perino, Clément Mathieu, et al.Frontiers in Psychiatry|July 18, 2022
Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free UseCélian Bertin, Julien Bezin, Chouki Chenaf, et al.Pageof 37